Notice Number: NOT-DE-19-006
Key Dates
Release Date: April 25, 2019
PAR-19-193
Issued by
National Institute of Dental and Craniofacial Research (NIDCR)
Purpose
This notice informs potential applicants that the National Institute of Dental and Craniofacial Research is participating in PAR-19-193, " "Microbial-based Cancer Therapy-Bugs as Drugs (R01- Clinical Trial Not Allowed)".
The following changes have been made to reflect NIDCR's participation in this FOA:
Part 1. Overview Information
Components of Participating Organizations
National Cancer Institute (NCI)
National Institute on Dental and Craniofacial Research (NIDCR)
Catalog of Federal Domestic Assistance (CFDA) Numbers
93.396, 93.121
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
The NIDCR is interested in all applications that are relevant to the NIDCR mission and strategic plan.
Potential applicants are encouraged to speak with a NIDCR program official to discuss the relevance of proposed research topic(s).
Section VII. Agency Contacts
The following contacts have been added:
Scientific/Research Contact(s)
Chiayeng Wang, Ph.D.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-827-4647
Email: [email protected]
Financial/Grants Management Contact(s)
Diana Rutberg, M.B.A.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-4798
E-mail: [email protected]
Inquiries
Please direct all inquiries to:
Chiayeng Wang, Ph.D.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-827-4647
Email: [email protected]
and Human Services (HHS)
